Skip to main content
. Author manuscript; available in PMC: 2013 Jun 1.
Published in final edited form as: J Surg Res. 2012 Sep 8;182(1):85–93. doi: 10.1016/j.jss.2012.08.053

Figure 4.

Figure 4

131I uptake of WRO cells following transfection of 20 nmol of siRNABRAF when grown in three different TSH environments: no TSH (H5), physiologic TSH (H6), and media supplemented with 50x the physiologic concentration of TSH (supratherapeutic). 131I uptake did not increase in TSH-free media, increased by 7.5-fold (p<0.01) in physiologic TSH media, and increased by 9.1 fold (p<0.01) in supratherapeutic TSH media 72 hours after siRNA transfection. Non-transfected WRO cells and WRO cells transfected with non-silencing siRNA grown in all three media conditions are shown as negative controls.